Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine (scientific article)

cites work (P2860)

Q38001080	"IDEAL" vaccines for resource poor settings
Q39344325	18β-glycyrrhetinic acid inhibits rotavirus replication in culture
Q34227701	2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis
Q57108439	6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID)
Q46956714	A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis
Q36871949	A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants
Q33455756	A Rapid Epidemiological Tool to Measure the Burden of Norovirus Infection and Disease in Resource-Limited Settings
Q47116624	A benefit-risk analysis of rotavirus vaccination, France, 2015.
Q64137151	A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness
Q37514764	A critical literature review of health economic evaluations of rotavirus vaccination
Q37547272	A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix
Q40074888	A cross-sectional study of acute diarrhea in Pudong, Shanghai, China: prevalence, risk factors, and healthcare-seeking practices.
Q39790135	A first report on the characterization of rotavirus strains in Sierra Leone
Q54401995	A hospital based study on inter- and intragenotypic diversity of human rotavirus A VP4 and VP7 gene segments, Germany
Q51764839	A mathematical model of the indirect effects of rotavirus vaccination.
Q34029254	A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus
Q30633803	A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data.
Q51171028	A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions
Q37715611	A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins
Q39194016	A phase I clinical trial of a new 5-valent rotavirus vaccine
Q33303057	A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers
Q42657149	A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
Q34068554	A retrospective analysis of acute gastroenteritis agents in children admitted to a university hospital pediatric emergency unit
Q59350114	A review of recommendations for rotavirus vaccination in Europe: Arguments for change
Q36256433	A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel
Q26820819	A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy
Q33517961	A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials
Q36732495	Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability
Q61918194	Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India
Q82789111	Acute gastroenteritis caused by multiple enteric pathogens in children
Q24676344	Acute gastroenteritis in children
Q36904890	Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy
Q37285708	Acute viral gastroenteritis in children hospitalized in Iksan, Korea during December 2010-June 2011.
Q39182828	Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men.
Q55381145	Adoption of rotavirus vaccine by U.S. physicians: progress and challenges.
Q45397864	Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles.
Q36000457	An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface
Q83842085	An economic analysis of rotavirus vaccination in Italy
Q37762543	An update on management of severe acute infectious gastroenteritis in children.
Q43716574	Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
Q36978394	Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).
Q38067243	Animal models for neonatal diseases in humans
Q26783530	Anti-infective vaccination in the 21st century-new horizons for personal and public health
Q35443349	Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.
Q38467394	Antigenemia, RNAemia, and innate immunity in children with acute rotavirus diarrhea
Q92320554	Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries
Q58892227	Assessing the introduction of universal rotavirus vaccination in the Netherlands
Q90481177	Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis
Q36684586	Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
Q37713807	Association of rotavirus strains and severity of gastroenteritis in Indian children
Q30773449	Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine: a preliminary report of re-analyses of data from a Cochrane Database Systematic Review
Q55348211	Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
Q51552566	Beyond efficacy: The full public health impact of vaccines.
Q31146806	Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia.
Q30229074	Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus
Q42201985	Bovine rotavirus pentavalent vaccine development in India
Q46790602	Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception
Q42247742	Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain
Q36455793	Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia
Q36887357	Burden of disease & molecular epidemiology of group A rotavirus infections in India
Q33495433	Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis.
Q33653590	Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.
Q80608220	Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France
Q37366751	Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec
Q34115533	Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review
Q44766361	Burden of severe rotavirus disease in Australia.
Q43822269	Burden on UK secondary care of rotavirus disease and seasonal infections in children
Q57808456	Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls
Q57097648	Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia
Q40354451	Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel
Q34574440	Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization
Q34820154	Changing profile of rotavirus genotypes in Bangladesh, 2006-2012
Q36584400	Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines
Q43797814	Characteristics of an ideal rotavirus vaccine
Q34018952	Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era.
Q33768166	Child feeding practices and diarrheal disease among children less than two years of age of the nomadic people in Hadaleala District, Afar Region, Northeast Ethiopia.
Q36155443	Childhood immunisation: what is the future?
Q34275545	Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa
Q38566314	Chitosan-based mucosal adjuvants: Sunrise on the ocean
Q40159624	Clean water, clean hands or new vaccines?
Q56787288	Clinical Characteristics of Nosocomial Rotavirus Infection in Children in Taiwan
Q36978372	Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States
Q44304042	Clinical and molecular epidemiology of norovirus infection in childhood diarrhea in China
Q36896314	Clinical update: rotavirus gastroenteritis and its prevention
Q85013353	Comment on the contribution by Weycker et al., “Cost of routine immunization of young children against rotavirus infection with Rotarix® versus RotaTeq®”
Q37089583	Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua
Q37101530	Community management of acute malnutrition in the developing world
Q36282707	Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens
Q37530403	Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles
Q33955841	Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
Q34719720	Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India
Q39869593	Comparing biomarkers as trial level general surrogates
Q81955561	Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children
Q37085086	Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis
Q41463942	Comparison of Vesikari and Clark scales regarding the definition of severe rotavirus gastroenteritis in children
Q28257258	Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study
Q47832345	Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia
Q42266012	Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine
Q34077813	Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E
Q33848262	Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial
Q36157186	Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children
Q45281590	Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance
Q84744021	Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis
Q59360996	Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines
Q41546108	Conquering rotavirus: from discovery to global vaccine implementation
Q38033977	Consensus recommendations on immunization and IAP immunization timetable 2012.
Q37563622	Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries
Q34577280	Contributions of Native Americans to the global control of infectious diseases
Q38281298	Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings
Q38683902	Correlates of protection for enteric vaccines
Q35886464	Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges
Q56793962	Cost and cost-effectiveness of childhood vaccination against rotavirus in France
Q33835633	Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Q36111776	Cost effectiveness of infant vaccination for rotavirus in Canada
Q59692197	Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq
Q47861443	Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
Q41279252	Cost-effectiveness analysis of rotavirus vaccination in Argentina
Q38445972	Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Q37398811	Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model
Q42235703	Cost-effectiveness of childhood rotavirus vaccination in Germany
Q44938367	Cost-effectiveness of childhood rotavirus vaccination in Taiwan
Q51830023	Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK.
Q38864030	Cost-effectiveness of rotavirus vaccination in Albania
Q51225751	Cost-effectiveness of rotavirus vaccination programs in Taiwan
Q38551664	Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium
Q86694278	Cost-effectiveness of rotavirus vaccines in British Columbia: Responding to: Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation [Vaccine
Q48616571	Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland
Q91878464	Current and new rotavirus vaccines
Q38603768	Current status of rotavirus vaccines
Q37420608	Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013.
Q42007674	Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine
Q33883799	Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis
Q51157393	Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme
Q30276748	Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial
Q34441419	Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics
Q34663993	Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas
Q46077494	Des recommandations quant à l’usage des vaccins antirotavirus chez les nourrissons
Q41859722	Detection and characterization of group C rotaviruses in asymptomatic piglets in Ireland
Q54386651	Detection and characterization of human rotavirus in hospitalized patients in the cities of Ponta Grossa, Londrina and Assai - PR, Brazil.
Q42158105	Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan
Q41875733	Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization
Q38974879	Detection of Common, Emerging and Uncommon VP4, and VP7 Human Group A Rotavirus Genotypes from Urban Sewage Samples in Uruguay
Q54373306	Detection of G3P[3] and G3P[9] rotavirus strains in American Indian children with evidence of gene reassortment between human and animal rotaviruses.
Q36075467	Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines
Q35693547	Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine
Q36201298	Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs
Q36452525	Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes
Q37652537	Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq
Q30425503	Development of a stable insect cell line constitutively expressing rotavirus VP2.
Q37857326	Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine
Q38211748	Diagnosis of viral gastroenteritis in children: interpretation of real-time PCR results and relation to clinical symptoms
Q38174842	Diagnosis, management, and prevention of rotavirus gastroenteritis in children
Q33763060	Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
Q42221656	Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes
Q46243057	Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors
Q36175693	Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries
Q31086859	Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models
Q59134865	Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction
Q37671911	Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.
Q64131818	Disease and economic burden of rotavirus diarrhoea in India
Q34785330	Disease caused by rotavirus infection
Q51172197	Distribution of rotavirus genotypes causing nosocomial and community-acquired acute gastroenteritis at the Children's Hospital of Philadelphia in the new rotavirus vaccine era.
Q92051384	Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines
Q38235912	Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis
Q89970057	Divergence of group a rotavirus with genetic variations before and after introduction of rotavirus vaccines in northern Taiwan
Q37296744	Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum
Q41728495	Does preventing rotavirus infections through vaccination also protect against naturally occurring intussusception over time?
Q36175711	Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch
Q93051926	Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains
Q38242111	Early childhood diarrhoeal diseases and cognition: are we missing the rest of the iceberg?
Q40106056	Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland
Q37959559	Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome.
Q64126208	Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand
Q47856401	Economic burden of rotavirus disease in children under 5 years in Kazakhstan.
Q30909743	Economic evaluation of a routine rotavirus vaccination programme in Indonesia
Q40496831	Economic evaluation of routine infant rotavirus immunisation program in Japan
Q102319163	Economic evaluation of the introduction of rotavirus vaccine in Hong Kong
Q46653876	Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea
Q37909422	Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
Q45260893	Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit
Q37668175	Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa
Q37425479	Effect of human rotavirus vaccine on severe diarrhea in African infants
Q40045569	Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis
Q40791967	Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries
Q46195093	Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation
Q38176032	Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.
Q40722616	Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study
Q40722658	Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
Q40722649	Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua
Q39512394	Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda
Q36356363	Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.
Q90423869	Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children
Q40227989	Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study
Q36942818	Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study
Q33915516	Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study
Q36149373	Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study
Q39092372	Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study
Q37452293	Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA.
Q35830008	Effectiveness of rotavirus vaccine in preventing severe acute gastroenteritis in children.
Q37375983	Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status
Q26741847	Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis
Q93034346	Effectiveness of rotavirus vaccines in an Australian population: A case-control study
Q82707061	Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain
Q35154120	Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain
Q36245512	Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design
Q42227014	Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study
Q37498366	Effects of Escherichia coli Nissle 1917 and Ciprofloxacin on small intestinal epithelial cell mRNA expression in the neonatal piglet model of human rotavirus infection
Q89580859	Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis
Q46390356	Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
Q49955396	Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial
Q37530043	Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial
Q34432275	Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life
Q35941163	Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial
Q45274597	Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).
Q79958029	Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
Q37695264	Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial
Q92615046	Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials
Q39944921	Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
Q38879736	Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
Q46579180	Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
Q46793235	Efficacy of the oral pentavalent rotavirus vaccine in Mali
Q34146235	Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study
Q36974911	Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period
Q36249319	Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.
Q61700300	Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial
Q64103400	Efficient recovery and enrichment of infectious rotavirus using separation with antibody-integrated graphite-encapsulated magnetic nanobeads produced by argon/ammonia gas plasma technology
Q36539869	Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007.
Q47595679	Emergence of G9P[8] rotaviruses in children with acute gastroenteritis in Thailand, 2015-2016.
Q36377394	Emergence of Rotavirus G12P[8] in St. Louis During the 2012-2013 Rotavirus Season
Q44346442	Emergence of an unusual genotype of rotavirus in andaman and nicobar islands, India.
Q33430511	Emergence of unusual human rotavirus strains in Salento, Italy, during 2006-2007
Q36440493	Emerging vaccines: evidence and considerations for practice integration.
Q91360178	Enhancing immune responses to oral vaccines: still an enigma
Q30443288	Enteric infections, diarrhea, and their impact on function and development
Q47561564	Enteric viruses in surface waters from Argentina: molecular and viable virus detection
Q35910518	Enteropathies in the developing world: neglected effects on global health
Q44521566	Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France.
Q45252066	Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005-2006.
Q40202918	Epidemiology and genetic diversity of classic human astrovirus among hospitalized children with acute gastroenteritis in Uruguay
Q39626814	Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in southwest China
Q34795202	Epidemiology and genetic diversity of rotavirus strains in children with acute gastroenteritis in Lahore, Pakistan
Q34288174	Epidemiology and prospects for prevention of rotavirus disease in India
Q39353263	Epidemiology of Rotavirus in the Iranian Children: A Systematic Review and Meta-analysis.
Q48529071	Epidemiology of childhood intussusception in Bangladesh: Findings from an active national hospital based surveillance system, 2012-2016.
Q33776112	Epidemiology of rotavirus infection among young children with acute diarrhoea in Burkina Faso
Q51129407	Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy
Q30276185	Epidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS)
Q49797351	Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia
Q37365715	Estimated mortality and hospital admission due to rotavirus infection in the WHO European region.
Q38612845	Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.
Q36774675	Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India
Q46790381	Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia
Q47005046	Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres
Q33474787	Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis
Q33651068	Etiology of diarrhea in older children, adolescents and adults: a systematic review
Q63881009	Etiología y manejo de la gastroenteritis aguda infecciosa en niños y adultos
Q50801671	Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease
Q53198731	Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
Q92623430	Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi
Q35909569	Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children
Q38416924	Evaluating the health impact of a public-private partnership: to reduce rotavirus disease in Nicaragua
Q38947795	Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
Q37014380	Evaluating the safety of a rotavirus vaccine: the REST of the story
Q41992194	Evaluation and comparison of predictive individual-level general surrogates
Q92267944	Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa
Q43687125	Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana
Q51157129	Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece
Q37636873	Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
Q35947992	Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants
Q35137102	Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries
Q43662952	Evidence of interspecies transmission and reassortment among avian group A rotaviruses
Q42638130	Evidence of intragenic recombination in G1 rotavirus VP7 genes
Q41046228	Evolution of human G4P[8] group A rotavirus strains circulating in Italy in 2013.
Q35784668	Evolutionary history and global spread of the emerging g12 human rotaviruses
Q83656661	Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan
Q64130682	Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
Q31137956	Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells
Q36750239	Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom
Q57178120	Exploring the relationship between environmental enteric dysfunction and oral vaccine responses
Q37395367	FIRST MOLECULAR DETECTION AND VP7 (G) GENOTYPING OF GROUP A ROTAVIRUS BY SEMI-NESTED RT-PCR FROM SEWAGE IN NIGERIA.
Q44960518	Financing children's vaccines
Q38039625	Financing vaccinations - the South African experience
Q90003463	First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina
Q44800567	First year experience of rotavirus immunisation programme in Finland
Q38998392	Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines
Q46523533	Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis
Q43981036	From structural and antigenic features of the rotavirus to the development of the vaccines
Q38022320	Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
Q84500544	Gastroenteritis in children
Q84595951	Gastroenteritis in children
Q37233997	Gastroenterology in developing countries: issues and advances
Q35806976	Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq
Q36181323	Genetic analysis of G12P[8] rotaviruses detected in the largest U.S. G12 genotype outbreak on record
Q90205167	Genetic characterization of group-A rotaviruses among children in eastern India during 2014-2016: Phylodynamics of co-circulating genotypes
Q36172686	Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.
Q41350844	Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions
Q41988136	Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India.
Q39987262	Genotype diversity of group A rotavirus strains in children with acute diarrhea in urban Burkina Faso, 2008-2010
Q39746335	Genotypes of rotavirus strains circulating in Amman, Jordan, in 2006/07 and their significance for the potential effectiveness of future rotavirus vaccination
Q38975432	Genotypic Distribution of Rotavirus in Phnom Penh, Cambodia: An Association of G9 with More Severe Diseases
Q54343219	Genotyping of human rotaviruses circulating among children with diarrhea in Valencia, Venezuela.
Q35482824	Genotyping rotavirus RNA from archived rotavirus-positive rapid test strips
Q38826540	Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea
Q36371703	Global economic evaluations of rotavirus vaccines: A systematic review
Q34108591	Global impact of rotavirus vaccines
Q34299983	Global issues related to enteric viral infections
Q64054487	Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017
Q38068232	Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?
Q40722565	Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward
Q47573959	Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries
Q53409378	Healthy-days time equivalents for outcomes of acute rotavirus infections.
Q39343861	Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria
Q34789779	Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: Implications for surveillance
Q54225127	High prevalence of G3 rotavirus in hospitalized children in Rawalpindi, Pakistan during 2014.
Q30234848	Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy
Q36588299	Homecare issues in rotavirus gastroenteritis
Q58438692	Hospital acquired rotavirus infections: burden in Canadian paediatric hospitals
Q37591888	Hospital-based Surveillance for Rotavirus Gastroenteritis Among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program
Q50800593	Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan
Q44595188	Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007.
Q33794728	Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania
Q33726130	Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy
Q38673443	Hospitalised rotavirus gastroenteritis in New Zealand: The laboratory database is a valuable tool for assessing the impact of rotavirus vaccination
Q34052380	Hospitalizations due to rotavirus gastroenteritis in Catalonia, Spain, 2003-2008.
Q36235204	Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States
Q36997199	Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador
Q39066570	Human P[6] Rotaviruses From Sub-Saharan Africa and Southeast Asia Are Closely Related to Those of Human P[4] and P[8] Rotaviruses Circulating Worldwide.
Q33644772	Human infection with G12 rotaviruses, Germany
Q35792185	Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain
Q35109584	Human rotavirus group a serotypes causing gastroenteritis in children less than 5 years and HIV-infected adults in Viwandani slum, Nairobi
Q64927193	Human rotavirus in Iran; molecular epidemiology, genetic diversity and recent updates on vaccine advances.
Q36026167	Human rotavirus serotype G9, São Paulo, Brazil, 1996-2003
Q37713426	Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].
Q34271468	Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China
Q36291026	Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.
Q81037003	Human rotavirus vaccines: too early for the strain to tell
Q38081968	Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease
Q36506334	Identification by full-genome analysis of a bovine rotavirus transmitted directly to and causing diarrhea in a human child
Q42173469	Identification of a G2-like porcine rotavirus bearing a novel VP4 type, P[32]
Q79872372	Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice
Q46008918	Identification of lineage III of G12 rotavirus strains in diarrheic children in the Northern Region of Brazil between 2008 and 2010.
Q38059916	Immune responses and protection in children in developing countries induced by oral vaccines
Q34291161	Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Q24626023	Immune responses to rotavirus infection and vaccination and associated correlates of protection
Q36728581	Immunization in Canada: Update for 2015.
Q81401502	Immunization update
Q37646974	Immunization update II.
Q40541626	Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
Q21245322	Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
Q37473348	Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model
Q37134934	Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
Q84384797	Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe
Q36887973	Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants
Q42201983	Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants
Q91941519	Immunogenicity of pentavalent rotavirus vaccine in Chinese infants
Q47251751	Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction
Q57935032	Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam
Q47832209	Immunogenicity of the pentavalent rotavirus vaccine in African infants
Q28972559	Immunology of Gut Mucosal Vaccines
Q36781552	Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana
Q42210076	Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial
Q50147691	Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.
Q37530039	Impact of rotavirus vaccination in Australian children below 5 years of age: a database study
Q58232513	Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil
Q50156986	Impact of rotavirus vaccination on epidemiological dynamics in England and Wales
Q30000818	Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data
Q59176456	Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study
Q97565448	Impact of rotavirus vaccination on intussusception hospital admissions in England
Q44094211	Impact of rotavirus vaccination on laboratory confirmed cases in Belgium
Q38638982	Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children
Q92338476	Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study
Q43924082	Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa
Q64137346	Impact of rotavirus vaccines in Sub-Saharan African countries
Q38018979	Impact of rotavirus vaccines on rotavirus disease
Q43534254	Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience
Q36966129	Impacts of national surveillance for uncommon conditions in childhood.
Q57029745	Impfstoffe gegen Durchfallserkrankungen – am Beispiel der Impfstoffe gegen Reisediarrhoe und gegen Rotavirus
Q34196755	Implementation of a universal rotavirus vaccination program: comparison of two delivery systems
Q53228735	Implementing rotavirus vaccination in Asia.
Q84431082	Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets
Q37308484	Inactivated rotavirus vaccines: a priority for accelerated vaccine development
Q33354568	Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya
Q50029910	Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013.
Q34538651	Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study
Q51140812	Incidence of hospitalization due to community-acquired rotavirus infection: a 12-year study (1996-2008).
Q35011035	Incidence of intussusception in Singaporean children aged less than 2 years: a hospital-based prospective study
Q34434552	Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination
Q39258717	Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
Q36709727	Induction of secretory immunity and memory at mucosal surfaces
Q37284961	Infectious diseases and vaccine sciences: strategic directions
Q35225171	Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence
Q38004113	Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines
Q40379831	Inhibition of rotavirus infectivity by a neoglycolipid receptor mimetic
Q36992562	Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines
Q27024768	Insights from global data for use of rotavirus vaccines in India
Q45234850	Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories.
Q61804344	Interventions to improve oral vaccine performance: a systematic review and meta-analysis
Q43818454	Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge
Q93044680	Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation
Q36918275	Introduction of rotavirus vaccines in developing countries: remaining challenges.
Q41050653	Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
Q98183611	Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants
Q37622904	Intussusception and rotavirus vaccination: a review of the available evidence
Q35896246	Intussusception following rotavirus vaccination in the Valencia Region, Spain
Q38234440	Intussusception following rotavirus vaccination: an updated review of the available evidence
Q56638996	Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia
Q37291708	Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study
Q35537821	Intussusception in Australia: epidemiology prior to the introduction of rotavirus vaccine
Q61841114	Intussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India
Q96586349	Intussusception in children aged under two years in India: Retrospective surveillance at nineteen tertiary care hospitals
Q44246038	Intussusception in southern India: comparison of retrospective analysis and active surveillance
Q37706379	Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study.
Q44106887	Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
Q38714154	Intussusception-related Hospitalizations among Infants before and after Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.
Q44275068	Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
Q37264972	Issues in pediatric vaccine-preventable diseases in low- to middle-income countries
Q46899273	Issues with reducing the rotavirus-associated mortality by vaccination in developing countries
Q51848206	Keeping rotavirus vaccines on the international agenda.
Q40440945	Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program
Q36851125	Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination.
Q54385417	Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Q98243875	Long-term effectiveness of pentavalent and monovalent rotavirus vaccines against hospitalization in Taiwan children
Q42205162	Longitudinal analysis of VP7 gene of group A human rotavirus G2P[4] strains circulating in the pre-vaccine era in Sapporo, Japan from 1991 to 2011.
Q34053403	Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua
Q33767570	Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?
Q44489559	Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: which key messages in light of a new immunization program?
Q37145731	Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study
Q35819629	Medical records-based postmarketing safety evaluation of rare events with uncertain status
Q85918489	Medical records-based postmarketing safety evaluation of rare events with uncertain status
Q47832199	Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh
Q35635402	Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi
Q37917000	Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).
Q34647668	Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates
Q38646712	Microneedle patches for vaccination in developing countries.
Q39841648	Modeling nosocomial transmission of rotavirus in pediatric wards.
Q96229018	Modeling of rotavirus transmission dynamics and impact of vaccination in Ghana
Q39156516	Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
Q38882821	Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales
Q40317040	Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India
Q48064924	Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq
Q37875265	Molecular and infectivity studies of porcine circovirus in vaccines
Q38974615	Molecular characterisation of wild-type G1P[8] and G3P[8] rotaviruses isolated in Vietnam 2008 during a vaccine trial
Q37410447	Molecular characteristics of German G8P[4] rotavirus strain GER1H-09 suggest that a genotyping and subclassification update is required for G8
Q42912304	Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy.
Q37695267	Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi
Q39730985	Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009.
Q40545568	Molecular epidemiology of Rotavirus A, causing acute gastroenteritis hospitalizations among children in Nha Trang, Vietnam, 2007-2008: Identification of rare G9P[19] and G10P[14] strains
Q40254797	Molecular epidemiology of group A rotavirus among children admitted to hospital in Salto, Uruguay, 2011-2012: first detection of the emerging genotype G12.
Q42233115	Molecular epidemiology of human calicivirus infections in children with acute diarrhea in Shanghai: a retrospective comparison between inpatients and outpatients treated between 2006 and 2011.
Q38478818	Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain
Q41830616	Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 strains.
Q35913765	Molecular epidemiology of rotavirus in Central and Southeastern Europe.
Q43927864	Molecular epidemiology of rotaviruses in Bulgaria: annual shift of the predominant genotype.
Q43936551	Monitoring impact and effectiveness of rotavirus vaccination
Q38903526	Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease
Q54094430	Monitoring shedding of five genotypes of RotaTeq vaccine viruses by genotype-specific real-time RT-PCR assays.
Q37150315	Monitoring the impact of vaccines postlicensure: new challenges, new opportunities
Q37559647	Mucosal vaccines: novel advances in technology and delivery
Q36159791	Multicenter prospective study on the burden of rotavirus gastroenteritis in children less than 3 years of age in Spain
Q38463606	Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells
Q38599577	Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies
Q36945838	Needle-free vaccine delivery
Q36791315	Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India
Q38255552	New approaches in oral rotavirus vaccines
Q37880425	New approaches to the assessment of vaccine herd protection in clinical trials
Q36552854	New insights into rotavirus vaccines.
Q37370235	Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children
Q100393824	Norovirus and rotavirus in children hospitalized with diarrhoea after rotavirus vaccine introduction in Burkina Faso
Q35624658	Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007
Q33652978	Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.
Q36983970	Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010.
Q42850049	Nutritional Enteric Failure: Neglected Tropical Diseases and Childhood Stunting
Q38740212	Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule
Q57286668	Optimizing and evaluating biomarker combinations as trial-level general surrogates
Q30241442	Options for improving effectiveness of rotavirus vaccines in developing countries.
Q36903971	Oral rotavirus vaccines: how well will they work where they are needed most?
Q36892043	Oral vaccines: directed safe passage to the front line of defense
Q37694876	Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia
Q38654728	Ovine rotaviruses
Q41733628	Parental preferences for rotavirus vaccination in young children: a discrete choice experiment.
Q81548527	Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
Q40210004	Parenteral protein-based rotavirus vaccine
Q56342148	Pathophysiology of environmental enteric dysfunction and its impact on oral vaccine efficacy
Q31150059	Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial
Q37762246	Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe
Q36219068	Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease
Q24600612	Performance of rotavirus vaccines in developed and developing countries
Q38194216	Perspectives on the future of postmarket vaccine safety surveillance and evaluation
Q51692593	Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread.
Q46367207	Phylogenetic and computational structural analysis of VP7 gene of group a human rotavirus G1P[8] strains obtained in Sapporo, Japan from 1987 to 2000.
Q47298440	Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015-2016, with cogent genes of the Rotarix and RotaTeq vaccine strains.
Q64125113	Polio endgame: Lessons for the global rotavirus vaccination program
Q51138986	Population-based surveillance for severe rotavirus gastroenteritis in children in Karachi, Pakistan
Q38610724	Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine
Q51143331	Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
Q47422430	Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality
Q35923846	Potential for use of retinoic acid as an oral vaccine adjuvant
Q45822805	Potential intussusception risk versus benefits of rotavirus vaccination in the United States
Q40693674	Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines
Q90214218	Precision immunization: a new trend in human vaccination
Q89843470	Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants
Q33646176	Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination
Q33776603	Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil
Q38202176	Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop
Q47422424	Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal.
Q58603388	Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries
Q39790465	Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh
Q33913117	Prevalence of enteric infections among hospitalized patients in two referral hospitals in Ghana
Q35854529	Prevention and Control of Childhood Pneumonia and Diarrhea
Q34616273	Prevention and treatment of viral diarrhea in pediatrics
Q37012078	Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines
Q34064371	Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
Q37357576	Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams
Q36800681	Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs
Q43784089	Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium
Q47832226	Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
Q45202354	Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China
Q35194876	Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries
Q35941247	Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
Q34203915	Protective effect of natural rotavirus infection in an Indian birth cohort
Q37363974	Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
Q34291218	Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States
Q60179829	Quantification of Rotavirus Diarrheal Risk Due to Hydroclimatic Extremes Over South Asia: Prospects of Satellite-Based Observations in Detecting Outbreaks
Q52669110	Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study.
Q91975985	Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review
Q33901553	Rapid changes in rotaviral genotypes in Ecuador
Q41285657	Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations
Q38619905	Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.
Q36978426	Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: a post-marketing surveillance study
Q50776961	Ready to Measure Impact? The Introduction of Rotavirus Vaccine in India
Q40365313	Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel
Q34033770	Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples
Q38089933	Real-time quantitative polymerase chain reaction for virus infection diagnostics
Q98625964	Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis
Q38029250	Recent progress in mucosal vaccine development: potential and limitations
Q94420965	Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons
Q34115573	Recommendations for rotavirus vaccination: A worldwide perspective
Q34187771	Recommendations for the use of rotavirus vaccines in infants
Q87889452	Recommendations for the use of rotavirus vaccines in infants
Q39931509	Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine
Q37975416	Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review
Q37981766	Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality
Q28484524	Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis
Q84703962	Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009
Q48167285	Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).
Q45281060	Report of the second European expert meeting on rotavirus vaccination
Q47340934	Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
Q44516472	Research priorities regarding rotavirus vaccine and intussusception: a meeting summary
Q35066182	Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine
Q40405465	Resurgence of Rotavirus Genotype G12 in St. Louis During the 2014-2015 Rotavirus Season
Q36527126	Rethinking global access to vaccines
Q38004110	Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines
Q38236883	Retrospective surveillance for intussusception in children aged less than five years at two tertiary care centers in India
Q34083448	Retrospective surveillance for intussusception in children aged less than five years in a South Indian tertiary-care hospital.
Q38970217	Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization
Q33457458	Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
Q37123967	Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.
Q33654119	Risk of Intussusception After Rotavirus Vaccination
Q99710176	Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis
Q33601981	Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)
Q84824069	RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe
Q37340449	RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine
Q34574852	Rotarix (RIX4414): an oral human rotavirus vaccine
Q42775398	Rotarix in Japan: Expectations and Concerns
Q47610785	Rotarix® and RotaTeq® administration to preterm infants in the neonatal intensive care unit: Review of available evidence
Q37956376	Rotarix®: vaccine performance 6 years postlicensure
Q42248692	Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes
Q64132496	Rotavirus Gastroenteritis Infection Among Children Vaccinated and Unvaccinated With Rotavirus Vaccine in Southern China: A Population-Based Assessment
Q27009028	Rotavirus Infection in Children with Acute Gastroenteritis in Iran: A Systematic Review and Meta-analysis
Q35994839	Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems
Q38994750	Rotavirus Vaccination in India - Need for Surveillance of Intussusception
Q40048009	Rotavirus Vaccine Response Correlates with the Infant Gut Microbiota Composition in Pakistan
Q47547296	Rotavirus Vaccines: Effectiveness, Safety, and Future Directions
Q41589121	Rotavirus Vaccines: a story of success with challenges ahead
Q59712369	Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study
Q36520401	Rotavirus and rotavirus vaccines
Q39290987	Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.
Q33721409	Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi
Q37135255	Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine
Q40338858	Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin
Q37648707	Rotavirus disease and vaccination: impact on genotype diversity
Q51829359	Rotavirus disease and vaccines in India: a tremendous public health opportunity.
Q40379989	Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly
Q43365960	Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.
Q37165954	Rotavirus epidemiology: the Asian Rotavirus Surveillance Network.
Q33494098	Rotavirus gastroenteritis in Norway: analysis of prospective surveillance and hospital registry data
Q37089143	Rotavirus gastroenteritis in children under 5 years in the Kingdom of Bahrain: hospital-based surveillance
Q34071302	Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children
Q37359938	Rotavirus genotypes associated with childhood severe acute diarrhoea in southern Ghana: A cross-sectional study
Q36864908	Rotavirus genotypes in Malaysia and universal rotavirus vaccination
Q47549229	Rotavirus hospitalizations among children <5 years of age-Tajikistan, 2013-2014.
Q36173819	Rotavirus immune responses and correlates of protection
Q56762709	Rotavirus in Latin America: Current Situation and Perspectives
Q39836378	Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium
Q46152582	Rotavirus infection
Q35185921	Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model
Q44736456	Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005-2007.
Q36550022	Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies
Q28270926	Rotavirus infection: an update on management and prevention
Q37769212	Rotavirus infections and vaccines: burden of illness and potential impact of vaccination
Q39639810	Rotavirus infections in Detroit, USA, a region of low vaccine prevalence.
Q36316511	Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths
Q24299094	Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I
Q35494648	Rotavirus prevalence in the primary care setting in Nicaragua after universal infant rotavirus immunization
Q40210962	Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine
Q40314650	Rotavirus shedding in premature infants following first immunization
Q40393201	Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand
Q44329839	Rotavirus strain surveillance--an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007.
Q33812698	Rotavirus surveillance in Kisangani, the Democratic Republic of the Congo, reveals a high number of unusual genotypes and gene segments of animal origin in non-vaccinated symptomatic children
Q40608783	Rotavirus vaccination and infection induce VP6-specific IgA responses
Q37375904	Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries
Q42288802	Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castellón (Spain).
Q38206627	Rotavirus vaccination in Europe: drivers and barriers.
Q38039610	Rotavirus vaccination within the South African Expanded Programme on Immunisation.
Q36506780	Rotavirus vaccine (RotaTeq).
Q37944318	Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries
Q40030087	Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population
Q33875687	Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size
Q28727365	Rotavirus vaccine and intussusception
Q40551811	Rotavirus vaccine effectiveness in Hong Kong children
Q38445983	Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis
Q64087810	Rotavirus vaccine impact assessment surveillance in India: protocol and methods
Q44915328	Rotavirus vaccine introduction in the Americas: progress and lessons learned
Q53392521	Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
Q40873450	Rotavirus vaccine stability in the aquatic environment
Q38801789	Rotavirus vaccine strain transmission by vaccinated infants in the foster home
Q42550670	Rotavirus vaccine: a promise for the future.
Q56988239	Rotavirus vaccines
Q24654275	Rotavirus vaccines and pathogenesis: 2008
Q39187401	Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system
Q40298217	Rotavirus vaccines in Israel: Uptake and impact.
Q26853690	Rotavirus vaccines in routine use
Q79957957	Rotavirus vaccines must perform in low-income countries too
Q47119066	Rotavirus vaccines--balancing intussusception risks and health benefits
Q24657750	Rotavirus vaccines: an overview
Q79379362	Rotavirus vaccines: considerations for successful implementation in Europe
Q34550164	Rotavirus vaccines: current prospects and future challenges
Q27021385	Rotavirus vaccines: current status and future considerations
Q37081817	Rotavirus vaccines: how they work or don't work
Q36850161	Rotavirus vaccines: recent developments and future considerations.
Q45165657	Rotavirus vaccines: safety, efficacy and public health impact
Q94947290	Rotavirus vaccines: the role of researchers in moving evidence to action
Q35918823	Rotavirus vaccines: update on global impact and future priorities
Q37298870	Rotavirus vaccines: viral shedding and risk of transmission
Q59360403	Rotavirus vaccines: why continued investment in research is necessary
Q58289569	Rotavirus vaccines—An update
Q39589705	Rotavirus within day care centres in Oxfordshire, UK: characterization of partial immunity.
Q42280103	Rotavirus, respiratory syncytial virus and non-rotaviral gastroenteritis analysis of hospital readmissions in England and Wales
Q40479048	Rotavirus, vaccine failure or diagnostic error?
Q61700314	Rotavirus: realising the potential of a promising vaccine
Q26996393	Rotaviruses
Q33990547	Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication.
Q24609374	Rotaviruses: from pathogenesis to vaccination
Q36518775	Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Q56787285	Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
Q40141433	Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial
Q40529372	Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa
Q38797322	Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial
Q36978380	Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects
Q46630683	Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants
Q37992392	Safety reporting in developing country vaccine clinical trials-a systematic review
Q52658436	Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.
Q27487961	Sang Froid in a time of trouble: is a vaccine against HIV possible?
Q28388805	Seasonal Dynamics of the Airborne Bacterial Community and Selected Viruses in a Children's Daycare Center
Q24651505	Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis
Q42201947	Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains
Q54356989	Sequence analysis of human rotavirus strains: comparison of clinical isolates from Northern and Southern Italy.
Q34286201	Sequential generalized likelihood ratio tests for vaccine safety evaluation
Q44488487	Severity of rotavirus gastroenteritis in Indian children requiring hospitalization
Q92158537	Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1
Q47131606	Should India launch a national immunisation programme against rotavirus? Yes.
Q36179680	Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana
Q63880771	Structured surveillance of infectious intestinal disease in pre-school children in the community: ‘The Nappy Study’
Q36996665	Study on Rotavirus Infection and Its Genotyping in Children Below 5 Years in South West Iran
Q24197707	Surgical and non-surgical management for intussusception in children
Q24246078	Surgical and non-surgical management for intussusception in children
Q36450198	Surveillance and molecular characterization of group A rotaviruses in Goroka, Papua New Guinea
Q40530316	Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
Q40722641	Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization
Q39343850	Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria
Q28305259	Symptomatic and subclinical infection with rotavirus P[8]G9, rural Ecuador
Q38115368	Systematic documentation of new vaccine introduction in selected countries of the Latin American Region
Q38004108	Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.
Q34659711	Systemic rotavirus infection
Q40722593	Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa
Q90273310	Temporal decline in diarrhea episodes and mortality in Kiribati children two years following rotavirus vaccine introduction, despite high malnutrition rates: a retrospective review
Q38115374	Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries.
Q30300580	The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems
Q113697804	The Complex Interactions Between Rotavirus and the Gut Microbiota
Q94407769	The Economic Value of Vaccination: Why Prevention is Wealth
Q37600173	The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure.
Q37444783	The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005-2012).
Q82673369	The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital
Q84615729	The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old
Q26770871	The clinical development process for a novel preventive vaccine: An overview
Q36519692	The control of rotavirus gastroenteritis in the United States
Q38045661	The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales
Q84982289	The cost-effectiveness of rotavirus vaccination in Armenia
Q44902395	The cost-effectiveness of rotavirus vaccination in Australia
Q57515347	The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe
Q38594385	The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials
Q46309096	The detection and molecular characterization of human G12 genotypes in South Africa
Q92639992	The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines
Q53078390	The economic burden of rotavirus infection in South Korea from 2009 to 2012.
Q37815575	The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents
Q33754470	The effect of rotavirus vaccine on diarrhoea mortality
Q53096855	The effect of routine rotavirus vaccination on healthcare utilization for diarrhea in US children.
Q36958313	The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children
Q43173350	The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons
Q36389001	The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report
Q38172132	The gastrointestinal frontier: IgA and viruses
Q38551946	The health and economic burden of rotavirus disease in Belgium
Q34604662	The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections
Q34287906	The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices.
Q62486911	The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial
Q24647218	The impact of rotavirus gastroenteritis on the family
Q99201921	The impact of shared decision making with patient decision aids on the rotavirus vaccination rate in children: A randomized controlled trial
Q36953332	The influence of CD4+ CD25+ Foxp3+ regulatory T cells on the immune response to rotavirus infection
Q40425249	The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine
Q57530932	The occurrence of amino acid substitutions D96N and S242N in VP7 of emergent G2P[4] rotaviruses in Nepal in 2004-2005: a global and evolutionary perspective
Q38075076	The practice of pre-marketing safety assessment in drug development
Q39067681	The practice of travel medicine: guidelines by the Infectious Diseases Society of America
Q39693124	The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation
Q38162718	The risks of risk aversion in drug regulation
Q46678108	The rotavirus experience in Mexico: discovery to control
Q39232838	The rotavirus vaccine development pipeline.
Q36714677	The societal role of lifelong vaccination
Q38048555	The status of live viral vaccination in early life
Q36576880	The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
Q38009581	The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence
Q44811562	The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community
Q51338282	The use of an adequate mathematical model is crucial to evaluate vaccine effectiveness.
Q36490234	The use of cost-effectiveness analysis for pediatric immunization in developing countries
Q40044140	Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future
Q41145788	Three infants with rotavirus gastroenteritis complicated by severe gastrointestinal bleeding
Q42204913	Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit.
Q52643114	Timing and predictors of severe rotavirus gastroenteritis among unvaccinated infants in low- and middle-income countries.
Q42234885	Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants
Q91989138	Travelers' Diarrhea: A Clinical Review
Q42269528	Treatment and prevention of rotavirus infection in children
Q37186894	Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program
Q40575373	Trends in severe gastroenteritis among young children according to socio-economic characteristics before and after implementation of a rotavirus vaccination program in Quebec.
Q39353594	Unbiased whole-genome deep sequencing of human and porcine stool samples reveals circulation of multiple groups of rotaviruses and a putative zoonotic infection
Q34374045	Understanding reduced rotavirus vaccine efficacy in low socio-economic settings
Q44573092	Unexpected benefits of rotavirus vaccination in the United States
Q33601897	Unexpectedly high burden of rotavirus gastroenteritis in very young infants
Q39367699	Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
Q37640107	Update on Rotarix: an oral human rotavirus vaccine
Q46680344	Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
Q40722670	Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies
Q50937053	Use of Surveillance Data to Assess the Impact of Vaccination on Circulating Rotavirus Strains
Q46170199	Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children
Q21257223	Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries
Q45685379	Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology
Q35591138	Vaccination recommendations for Germany
Q34186752	Vaccine herd effect
Q93169067	Vaccine hesitancy : Report of a student study group
Q50665571	Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, Australia.
Q33920990	Vaccine-acquired rotavirus in infants with severe combined immunodeficiency
Q36025079	Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.
Q28080866	Vaccines against enteric infections for the developing world
Q34572829	Vaccines against traveler's diarrhoea and rotavirus disease - a review.
Q37045992	Vaccines at the turn of the 21st century: a new era for immunization in public health
Q91767150	Vaccines for enteric diseases
Q64117280	Vaccines for preventing rotavirus diarrhoea: vaccines in use
Q24197495	Vaccines for preventing rotavirus diarrhoea: vaccines in use
Q24203645	Vaccines for preventing rotavirus diarrhoea: vaccines in use
Q24235411	Vaccines for preventing rotavirus diarrhoea: vaccines in use
Q27004488	Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae
Q43595566	Vaccines: The real issues in vaccine safety
Q37058335	Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond
Q30977508	Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines
Q91909593	Viral gastroenteritis
Q91909624	Viral gastroenteritis
Q33602861	Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures
Q24596833	Water, sanitation, hygiene and enteric infections in children
Q101127656	What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Q44362569	What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program
Q35181316	Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa
Q44474941	Whole genome sequencing of lamb rotavirus and comparative analysis with other mammalian rotaviruses
Q36822928	Why does the world need another rotavirus vaccine?
Q44045362	Workshop on intussusception in African countries--meeting report.
Q35005253	Zoonotic aspects of rotaviruses
Q80142380	[2006 immunization plan--details of rotavirus vaccination]
Q79788721	[A pentavalent rotavirus vaccine: RotaTeq]
Q52591259	[Family impact of rotavirus gastroenteritis in children under two years].
Q81502330	[Rotavirus vaccination in France: recommendations of the French Speaking Group of Pediatric Gastroenterology, Hepatology and Nutrition]

P356	DOI	10.1056/NEJMOA052664
P698	PubMed publication ID	16394299

P50	author	Penelope H. Dennehy	Q37829307
		Mathuram Santosham	Q56425974
		Pierre Van Damme	Q64500305
		Leif Gothefors	Q124606931
		Kate O'Brien	Q6376501
		Paul A. Offit	Q7152812
P2093	author name string	Timo Vesikari
		Penny M Heaton
		Celia D C Christie
		Henry R Shinefield
		Aino Karvonen
		Joseph F Heyse
		Steven B Black
		H Fred Clark
		James P Watt
		Gary S Marshall
		Ben A Adeyi
		Mark J DiNubile
		Matthew T Onorato
		Michael J Dallas
		Michele L Coia
		John W Boslego
		Michelle G Goveia
		Robbin F Itzler
		David O Matson
		Samuli Ylitalo
		Dirk Campens
		Rotavirus Efficacy and Safety Trial (REST) Study Team
		Zoe Rodriguez
P433	issue	1
P407	language of work or name	English	Q1860
P921	main subject	vaccine	Q134808
P1104	number of pages	11
P304	page(s)	23-33
P577	publication date	2006-01-01
P1433	published in	The New England Journal of Medicine	Q582728
P1476	title	Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
P478	volume	354

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

scientific article

Reverse relations